CompletedPhase 1/2

Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program

Iran10 participantsStarted 2009-06

Plain-language summary

The purpose of this study is to investigate the efficacy and safety of cabergoline in prevention of ovarian hyperstimulation syndrome versus albumin in ART program.

Who can participate

Age range25 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients at risk of developing OHSS, defined by the development of 20-30 follicles larger than 12 mm in diameter and retrieval of more than 20 oocytes * ovarian stimulation with long protocol Exclusion Criteria: * coasting cases

What they're measuring

Percentage and severity of OHSS in two groups

Timeframe: 6 days after embryos transfer (ET)

Trial details

NCT IDNCT01009567

SponsorRoyan Institute

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2013-06

View on ClinicalTrials.gov More Ovarian Hyperstimulation Syndrome trials